Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02987985Phase 3Completed
A Phase 3 trial of ketamine, lidocaine, gabapentin, dexmedetomidine in sleep disordered breathing (SDB), obstructive sleep apnea (OSA), sponsored by University of Saskatchewan. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02987985.